New and Emerging Targeted Therapies for Pediatric Acute Myeloid Leukemia (AML)

The relapse rate for children with acute myeloid leukemia (AML) remains high despite advancements in risk classification, multi-agent chemotherapy intensification, stem cell transplantation, and supportive care guidelines. Prognosis for this subgroup of children with relapsed/refractory AML remains...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jing, Glasser, Chana L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072702/
https://www.ncbi.nlm.nih.gov/pubmed/32050659
http://dx.doi.org/10.3390/children7020012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072702/
https://www.ncbi.nlm.nih.gov/pubmed/32050659
http://dx.doi.org/10.3390/children7020012

Ejemplares similares